Femtech – technology addressing women's health needs across fertility, pregnancy, menstrual health, menopause, and breast cancer – is one of the fastest-growing health technology segments globally. Femtech companies are expanding across Southeast Asia, South Asia, and the Gulf where women's health has historically been underserved by both healthcare systems and technology investment. GreyRadius helps femtech companies validate consumer and clinical demand, navigate regulatory requirements, execute GTM plans, and raise capital.
Why now? Southeast Asia and South Asia have enormous femtech market potential – large, young female populations, high smartphone penetration, and significant underserved women's health needs. The Gulf's Vision 2030 programmes in Saudi Arabia and UAE national health strategies are creating funded demand for women's health technology. Companies establishing market positions in 2025–2027 are entering before the market becomes crowded.
The global femtech market is projected to reach $60B by 2027 growing at 15% annually – with Southeast Asia and South Asia representing the fastest-growing regional markets driven by large addressable populations.
Fertility and reproductive health is the largest femtech segment by revenue globally – but maternal health and menstrual health tracking are the fastest-growing segments in Southeast Asia and South Asia by user adoption.
B2B femtech is outperforming B2C in enterprise adoption – employer-provided women's health benefits are growing as corporates compete for female talent, creating a funded B2B channel that bypasses direct-to-consumer acquisition costs.
Telemedicine integration is becoming essential for femtech – hybrid digital-clinical models that combine app-based tracking with teleconsultation access are achieving higher retention than pure-play digital tools.
If you recognise your situation below, we can help.
Consumer demand validation
You need to validate that women in your target market want your femtech product – including health priority mapping, willingness to pay, and cultural acceptance research.
Regulatory classification and pathway
You need to understand how your femtech product is classified, what approvals are required, and what the clinical evidence requirements are in your target market.
GTM strategy for a femtech platform
You have a women's health app, device, or service and need a go-to-market strategy covering B2C consumer acquisition and B2B employer channel development.
Raising capital for a femtech venture
You are raising investment for a femtech company and need a pitch book grounded in consumer demand data and clinical evidence.
Healthcare system and insurer partnerships
You need to identify hospital systems, maternity clinics, and health insurers as distribution and reimbursement channel partners in your target market.
Cultural adaptation strategy
You need to understand how to adapt your femtech product, messaging, and clinical approach for culturally conservative markets in the Gulf and South Asia.
Every engagement is grounded in primary research and delivers a measurable outcome.
Validate consumer and clinical demand for your femtech product in a new market. Covers women's health consumer surveys, clinician interviews, regulatory classification mapping, and a Go/Defer/Kill recommendation.
Learn more →Full financial and operational feasibility for femtech platform launches. Covers consumer demand modelling, B2B employer channel sizing, revenue model, and investor-ready projections.
Learn more →End-to-end market entry for femtech companies. Regulatory pathway, clinical partner identification, employer B2B channel development, and first-user or first-employer acquisition.
Learn more →Embedded GTM team for femtech platforms. Consumer acquisition execution, employer benefit channel development, and first-revenue milestone tracking.
Learn more →Investor-ready pitch books for femtech ventures. Consumer-demand-validated market sizing, clinical evidence narrative, and investor identification across women's health and digital health VC.
Learn more →AI use-case prioritisation in femtech – from cycle prediction and fertility optimisation to symptom pattern recognition and personalised health coaching.
Learn more →80% of our insight comes from first-party interviews with buyers, competitors, and regulators – not secondary data that everyone else has.
Our AI layer compresses research timelines by 60% and surfaces pattern-matching from 200+ prior mandates – so you get faster, deeper answers.
We measure success by first contracts signed, capital raised, and markets entered – not deliverables produced. Every mandate has a milestone.
200+
Projects delivered
100+
SaaS & tech clients
80%
Primary research-led
4
Countries / offices
HealthTech · Market Entry
HealthTech · GTM
HealthTech · Assessment
Both. We work with consumer-facing femtech platforms on market entry and GTM, and with clinical femtech and medical device companies on market entry and fundraising.
Southeast Asia, South Asia, the Gulf, and Africa – markets with large underserved women's health populations and growing femtech investment.
Typically 6–10 weeks for consumer demand research, regulatory mapping, and market entry strategy.
Yes. We have conducted women's health consumer research in culturally conservative markets using appropriate research methodologies and female research teams.
GreyRadius research notes, market entry signals, and sector briefs – delivered weekly. No fluff.
Not sure which engagement fits? Take our free 2-minute diagnostic →
Primary research. AI-enabled analysis, expert-reviewed. Outcomes-based delivery – across Southeast Asia, South Asia, Gulf, Africa.
